Home Applications 202012 Application 202012
Type ANDA
Sponsor MYLAN PHARMS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 EPROSARTAN MESYLATE EPROSARTAN MESYLATE TABLET;ORAL EQ 400MG BASE No No 002 EPROSARTAN MESYLATE EPROSARTAN MESYLATE TABLET;ORAL EQ 600MG BASE No Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202012-001 EPROSARTAN MESYLATE EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 A202012-002 EPROSARTAN MESYLATE EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-03-09 01:35 UTC 2022-03 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL AB 2011-11-16 3f01610625f2…2019-12-14 00:12 UTC 2019-12 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL AB RS 2011-11-16 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL AB 2011-11-16 b00525d2431f…2019-09-15 20:21 UTC 2019-09 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL AB RS 2011-11-16 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL AB 2011-11-16 ea99ee380514…2019-07-19 19:46 UTC 2019-07 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL AB RS 2011-11-16 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 053a50430f4f…2023-05-13 08:27 UTC 2023-05 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A202012-001 EPROSARTAN MESYLATE EQ 400MG BASE TABLET / ORAL 2011-11-16 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A202012-002 EPROSARTAN MESYLATE EQ 600MG BASE TABLET / ORAL 2011-11-16 f41ea6bd6efb…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 1 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0378-6629 Eprosartan Mesylate eprosartan mesylate Mylan Pharmaceuticals Inc. ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 32151 ORIG 2011-11-21